Enzymic hydrolysis of nicotinate esters: comparison between plasma and liver catalysis

References

• Abou El-Enein A., Hafez Y. S., Salem H., Abdel M. The role of nicotinic acid and inositol hexanicotinate as anticholesterolemic and antilipemic agents. Nutrition Reports International 1983; 28: 899–911
   Google Scholar
• Altomare C., Carotti A., Cellamare S., Ferappi M., Cagiano R., Renna G. QSAR analysis of chemical and serum-catalyzed hydrolysis of phenyl ester prodrugs of nipecotic acid. International Journal of Pharmaceutics 1988; 48: 91–102
   Google Scholar
• Ammon R. The enzymic cleavage of several pharmaceutical esters. Arzneimittelforschung 1977; 27: 944–949
   PubMed Web of Science ®Google Scholar
• Bundgaard H., Falch E., Larsen C., Mosher G. L., Mikkelson T. J. Pilocarpine prodrugs. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters. Journal of Pharmaceutical Sciences 1986a; 75: 775–783
   PubMed Web of Science ®Google Scholar
• Bundgaard H., Buur A., Chang S. -C., Lee V. H. L. Prodrugs of timolol for improved ocular delivery: synthesis, hydrolysis kinetics and lipophilicity of various timolol esters. International Journal of Pharmaceutics 1986b; 33: 15–26
   Web of Science ®Google Scholar
• Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. Journal of The American Medical Association 1975; 231: 360–381
   PubMed Web of Science ®Google Scholar
• Cramer R. D., III, Bunce J. D., Patterson D. E., Frank I. E. Crossvalidation, bootstrapping and partial least squares compared with multiple regression in conventional QSAR studies. Quantitative Structure-Activity Relationships 1988a; 7: 18–25
   Google Scholar
• Cramer R. D., III, Patterson D. E., Bunce J. D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. Journal of The American Chemical Society 1988b; 110: 5959–5967
   PubMed Web of Science ®Google Scholar
• Durrer A., Walther B., Racciatti A., Testa B. Convenient method for the analysis of nicotinic acid as a metabolite of nicotinate esters in various tissue homogenates. Journal of Chromatography 1989; 495: 256–262
   PubMedGoogle Scholar
• Durrer A., Walther B., Racciatti A., Boss G., Testa B. Structure-metabolism relationships in the hydrolysis of nicotinate esters by rat liver and brain subcellular fractions. Pharmaceutical Research 1991; 8: 832–839
   PubMed Web of Science ®Google Scholar
• Estus G. S., Mieyal J. J. Structure-activity relationship for deacetylation of a homologous series of phenacetin analogs and their N-hydroxy derivatives. Drug Metabolism and Disposition 1983; 11: 471–476
   PubMedGoogle Scholar
• Falch E., Krogsgaard-Larsen P., Christensen Vibeke A. Esters of isoguvacine as potential prodrugs. Journal of Medicinal Chemistry 1981; 24: 285–289
   PubMedGoogle Scholar
• Hansch C. Correlation analysis in the design of pharmacodynamic properties of drugs. Design of Biopharmaceutical Properties through Prodrugs and Analogs, E. B. Roche. American Pharmaceutical Association Academy of Pharmaceutical Sciences, Washington 1977; 57–67
   Google Scholar
• Hotz W. Nicotinic acid and its derivatives: a short survey. Advances in Lipid Research, Vol. 20, R. Paoletti, D. Kritchevsky. Academic Press, New York 1983; 195–217
   Google Scholar
• Junge W., Krisch K. The carboxylesterases/amidases of mammalian liver and their possible significance. CrC Critical Reviews in Toxicology 1975; 3: 371–434
   PubMedGoogle Scholar
• Lowry O. H., Rosebrough N. J., Farr L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Morgan A. M., Truitt E. B., Jr. Evaluation of acetylsalicylic acid esterase in aspirin metabolism. Journal of Pharmaceutical Sciences 1965; 54: 1940–1645
   Google Scholar
• Owen J. A., Nakatsu K. Diacetyl morphine hydrolases in human blood. Canadian Journal of Physiology and Pharmacology 1983; 61: 870–875
   PubMed Web of Science ®Google Scholar
• Reymond D., Chung G. N., Mayer J. M., Testa B. Lipophilicity measurements of nicotinates by reversed-phase high-performance liquid chromatography. Differences in retention behaviour, but similarities of log kw values in methanol-water and acetonitrile-water eluents. Journal of Chromatography 1987; 391: 97–109
   Google Scholar
• Steward D. J., Inaba T., Lucassen M., Kalow W. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clinical Pharmacology and Therapeutics 1979; 25: 464–468
   PubMed Web of Science ®Google Scholar
• Subissi A., Schiantarelli P., Biagi M., Sardelli G. Comparative evaluation of some pharmacological properties and side-effects of D-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acid. Atherosclerosis 1980; 36: 135–148
   PubMedGoogle Scholar
• Suzuki N., Nakamura T. Metabolism of the nicotinic acid moiety of d,l-α-tocopheryl nicotinate. Journal of Nutritional Science and Vitaminology 1983; 29: 93–103
   PubMedGoogle Scholar
• Tsujita T., Okuda H. Carboxylesterases in rat and human sera and their relationship to serum arylacylamidases and cholinesterases. European Journal of Biochemistry 1983a; 133: 215–220
   PubMedGoogle Scholar
• Tsujita T., Okuda H. Human liver carboxylesterase: properties and comparison with human serum carboxylesterase. Journal of Biochemistry 1983b; 94: 793–797
   PubMedGoogle Scholar
• Tsujita T., Nagai T., Okuda H. Purification and properties of human serum esterase. Biochimica et Biophysica Acta 1979; 570: 88–95
   PubMedGoogle Scholar
• van de Waterbeemd H., Testa B. Parametrization of lipophilicity. Advances in Drug Research, Vol. 16, B. Testa. Academic Press, London 1987; 85–225
   Google Scholar
• van de Waterbeemd H., Testa B., Marrel C., Cooper D. R., Jenner P., Marsden C. D. Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugs. Drug Design and Delivery 1987; 2: 135–143
   PubMedGoogle Scholar
• Verloop A., Hoogenstraaten W., Tipker J. Development and application of new steric substituent parameters in drug design. Drug Design, J. Ariëns. Academic Press, London 1976; 165–207
   Google Scholar
• Wernly-Chung G. N., Mayer J. M., Tsantili-Kakoulidou A., Testa B. Structure-reactivity relationships in the chemical hydrolysis of prodrug esters of nicotinic acid. International Journal of Pharmaceutics 1990; 63: 129–134
   Web of Science ®Google Scholar